IDO2: Indoleamine 2,3-Dioxygenase 2
A key immunomodulatory enzyme in tryptophan catabolism and immune tolerance
Gene Information Card
| Symbol | IDO2 |
|---|---|
| Full Name | Indoleamine 2,3-Dioxygenase 2 |
| Gene Type | Protein coding |
| Chromosomal Location | 8p11.21 |
| NCBI Gene ID | 169355 ncbi.nlm.nih.gov/gene/169355 |
| Ensembl ID | ENSG00000188676 |
| UniProt ID | Q6ZQW0 |
| OMIM ID | 612129 |
| HGNC ID | 27276 |
| Aliases | INDOL1, IDO-2, indoleamine-pyrrole 2,3-dioxygenase-like 1 |
Description
IDO2 encodes indoleamine 2,3-dioxygenase 2, a heme-containing enzyme that catalyzes the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism. It converts L-tryptophan to N-formylkynurenine. IDO2 is expressed in antigen-presenting cells and plays a role in immune regulation, T-cell suppression, and establishing peripheral immune tolerance. It is implicated in cancer immune evasion, autoimmune diseases, and chronic inflammatory conditions.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (various) | IDO2 expression in tumors promotes immune escape by depleting tryptophan and producing kynurenines that suppress T-cell activity | PMID: 17671174; COSMIC |
| Rheumatoid arthritis | Elevated IDO2 activity in synovial tissue contributes to local tryptophan depletion and immune dysregulation | PMID: 21931327 |
| Alzheimer's disease | Upregulation of IDO2 in brain regions may contribute to neuroinflammation via kynurenine pathway metabolites | PMID: 20074504 |
| Systemic lupus erythematosus | IDO2 polymorphisms associated with altered tryptophan metabolism and disease susceptibility | PMID: 21931327 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Kidney | 3.2 | Low |
| Liver | 2.1 | Low |
| Lung | 1.5 | Low |
| Spleen | 1.8 | Low |
| Placenta | 4.5 | Medium |
| Brain | 1.0 | Low |
| Small intestine | 2.0 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 0.8 | Low expression |
| HeLa | 1.2 | Low expression |
| THP-1 | 2.5 | Moderate expression after IFN-γ stimulation |
| Jurkat | 0.5 | Very low expression |
| HepG2 | 1.0 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| R248W | Missense | Rare | Reduced catalytic activity; associated with altered immune regulation |
| Y359X | Nonsense | Rare | Loss of function; truncated protein |
| V359I | Missense | Common (SNP rs10109853) | Reduced enzyme activity; linked to autoimmune disease susceptibility |
Mutation functional classification
Loss of Function (LOF)
R248W and Y359X mutations reduce or abolish IDO2 enzymatic activity, impairing tryptophan catabolism and immune suppression.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in IDO2.
Dominant Negative (DN)
No dominant-negative mutations described for IDO2.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Kynurenine pathway (tryptophan degradation)
• Tryptophan metabolism (KEGG: hsa00380)
• Immune regulation via tryptophan catabolism
Protein Summary
IDO2 is a 420-amino acid heme-dependent dioxygenase that catalyzes the conversion of L-tryptophan to N-formylkynurenine. It shares structural homology with IDO1 but has distinct substrate specificity and lower catalytic efficiency. IDO2 is expressed primarily in antigen-presenting cells and is induced by inflammatory stimuli such as IFN-γ. It contributes to immune tolerance by depleting tryptophan and generating kynurenines that suppress effector T cells and promote regulatory T cell differentiation. Dysregulation of IDO2 is implicated in cancer immune evasion, autoimmune diseases, and chronic inflammation.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IDO2 Knockout HEK293 Cell Line | EDJ-KQ2939 | Human | 169355 | Details Get a Quote |
| IDO2 Knockout HeLa Cell Line | EDJ-KQ58923 | Human | 169355 | Details Get a Quote |
| IDO2 Knockout A-549 Cell Line | EDJ-KQ67411 | Human | 169355 | Details Get a Quote |
| IDO2 Knockout HCT 116 Cell Line | EDJ-KQ75805 | Human | 169355 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records